tradingkey.logo

Eikon Therapeutics Ord Shs

EIKN
14.500
-0.500-3.33%
Close 02/06, 16:00ETQuotes delayed by 15 min
--Market Cap
--P/E TTM

Eikon Therapeutics Ord Shs

14.500
-0.500-3.33%

More Details of Eikon Therapeutics Ord Shs Company

Eikon Therapeutics, Inc. is a United States-based drug discovery and development company. The Company’s platform allows resolution microscopy as well as the advances in biology, chemistry, engineering, and automation. It tracks and measures the real-time movement of individual proteins in living cells to understanding of disease biology and discover differentiated therapeutics.

Eikon Therapeutics Ord Shs Info

Ticker SymbolEIKN
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security typeOrdinary Share
Fiscal year-end- -
Address3929 Point Eden Way
City
Stock exchangeNASDAQ OMX - NASDAQ BASIC
Country- -
Postal code94545
Phone
Website
Ticker SymbolEIKN
IPO date- -
CEO- -

Company Executives of Eikon Therapeutics Ord Shs

Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%

Institutional Shareholding

Relevant data have not been disclosed by the company yet.
Reporting Period
No. of institutions
Shares Held
Proportion
Change
No Data

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
No Data

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI